NCT07742683Not yet recruiting
Digital Psychosocial Interventions on Stigma and Health Outcomes in TB Patients
The Impact of Digital Psychosocial Interventions on Stigma and Health Outcomes in Tuberculosis Patients
Source: ClinicalTrials.gov · Last updated 3 Aug 2026
Brief summary (registry, in English)
This study addresses the shortcomings of routine clinical management for tuberculosis (TB) patients by proposing psychosocial interventions targeting stigma, while investigating the current status of stigma, psychological issues, medication adherence, and drug resistance among tuberculosis patients. It analyzes the underlying mechanisms, integrates online mindfulness courses, digital cognitive behavioral therapy (CBT), and human-machine interactive dialogue modules to develop a digital psychosocial intervention platform. Through a randomized controlled trial, the study validates the impact of the platform on stigma and health outcomes among tuberculosis patients in China. Ultimately, the research aims to formulate a scalable digital psychosocial intervention technical solution, providing evidence-based support for optimizing China's comprehensive tuberculosis prevention and control model.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 496 (estimated)
- First submitted
- 27 Jul 2026
- Start date
- 1 Oct 2026
- Primary completion date
- 30 Sept 2027
- Lead sponsor
- Peking Union Medical College
- Diseases
- Tuberculosis
- NCT number
- NCT07742683
What you commit to
- Study type: Interventional
- Planned participants: 496
- From 1 Oct 2026 to the primary completion date, 30 Sept 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- 1\. Inclusion Criteria
- Aged 18 years or older.
- Patients diagnosed with active pulmonary tuberculosis within the past 1 year via bacteriological tests (smear microscopy or culture) and/or molecular biological assays (e.g., GeneXpert).
- Capable of independently completing questionnaires and scale assessments; accessible for sputum collection, chest radiography, biomarker testing and other examinations.
- Provided full informed consent for the entire study and signed the written informed consent form.
- 2\. Exclusion Criteria
- Presence of severe chronic diseases such as immune system disorders, or severe neurological and psychiatric disorders.
- No access to electronic devices required for subsequent online intervention.
- Cognitive impairment or hearing loss that impairs normal communication and prevents cooperation with surveys and intervention procedures.
- Concurrent participation in other health promotion or clinical intervention studies.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.